These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains. Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161 [TBL] [Abstract][Full Text] [Related]
64. TOBI Podhaler for cystic fibrosis patients with Pseudomonas aeruginosa. Farinde A Nurse Pract; 2015 Jul; 40(7):16-7. PubMed ID: 26080292 [No Abstract] [Full Text] [Related]
65. Moving Beyond Antibiotics: Exploring the Potential of an Antivirulence Monoclonal Antibody against Crabbé A Am J Respir Crit Care Med; 2024 Jul; 210(1):8-9. PubMed ID: 38780075 [No Abstract] [Full Text] [Related]
66. A case report of the eradication of pseudomonas aeruginosa from leg ulcer in a patient with essential thrombocythemia. Savini V; Catavitello C; Bianco A; Balbinot A; D'Antonio D Int J Low Extrem Wounds; 2009 Jun; 8(2):117-9. PubMed ID: 19443901 [TBL] [Abstract][Full Text] [Related]
67. Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven? Visser SK; Bye PTP; Fox GJ; Burr LD; Chang AB; Holmes-Liew CL; King P; Middleton PG; Maguire GP; Smith D; Thomson RM; Stroil-Salama E; Britton WJ; Morgan LC Lung; 2019 Dec; 197(6):803-810. PubMed ID: 31691027 [TBL] [Abstract][Full Text] [Related]
69. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients. Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102 [TBL] [Abstract][Full Text] [Related]
70. Clinical and microbiologic studies of carbenicillin. Michaeli D; Weinstein L J Infect Dis; 1970 Sep; 122():Suppl:S90-5. PubMed ID: 4990026 [No Abstract] [Full Text] [Related]
71. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients. Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669 [TBL] [Abstract][Full Text] [Related]
72. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. Kidd TJ; Ramsay KA; Vidmar S; Carlin JB; Bell SC; Wainwright CE; Grimwood K; J Cyst Fibros; 2015 May; 14(3):361-9. PubMed ID: 25563522 [TBL] [Abstract][Full Text] [Related]
73. Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. Follath F; Bindschedler M; Wenk M; Frei R; Stalder H; Reber H Eur J Clin Microbiol; 1986 Apr; 5(2):236-40. PubMed ID: 2941289 [TBL] [Abstract][Full Text] [Related]
74. Nebulized colistin for non-cystic fibrosis bronchiectasis: déjà vu all over again? Metersky ML; O'Donnell AE Am J Respir Crit Care Med; 2014 May; 189(10):1151-2. PubMed ID: 24754731 [No Abstract] [Full Text] [Related]
76. Spanish Guidelines on Treatment of Bronchiectasis in Adults. Martínez-García MÁ; Máiz L; Olveira C; Girón RM; de la Rosa D; Blanco M; Cantón R; Vendrell M; Polverino E; de Gracia J; Prados C Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):88-98. PubMed ID: 29128129 [TBL] [Abstract][Full Text] [Related]
77. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. Rayner CF; Tillotson G; Cole PJ; Wilson R J Antimicrob Chemother; 1994 Jul; 34(1):149-56. PubMed ID: 7961201 [TBL] [Abstract][Full Text] [Related]
78. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. Motbainor H; Bereded F; Mulu W BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693 [TBL] [Abstract][Full Text] [Related]
79. Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease. Kamata H; Asakura T; Suzuki S; Namkoong H; Yagi K; Funatsu Y; Okamori S; Uno S; Uwamino Y; Fujiwara H; Nishimura T; Ishii M; Betsuyaku T; Hasegawa N BMC Pulm Med; 2017 Dec; 17(1):198. PubMed ID: 29237500 [TBL] [Abstract][Full Text] [Related]
80. [Clinical implication and management of Pseudomonas aeruginosa colonization in patients with bronchiectasis]. Xu JF; Chai YH Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jul; 42(7):506-509. PubMed ID: 31365966 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]